Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 39 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
14 Sep 2026
Director
Sold on a plan
62,150
$566.99K
52.3%
6 Jul 2026
President and CEO
Sold on a plan
44,058
$364.05K
0.6%
12 Jun 2026
Director
Sold on a plan
27,000
$194.31K
50.0%
12 Jun 2026
Director
Sold on a plan
22,000
$158.80K
27.4%
7 Jan 2026
President and CEO
Sold on a plan
18,012
$105.89K
0.3%
2 Jan 2025
President and CEO
Sold on a plan
33,841
$106.66K
0.5%
3 Jan 2024
President and CEO
Sold on a plan
41,396
$185.70K
0.6%
3 Jul 2023
President and CEO
Sold on a plan
60,698
$200.98K
0.9%
3 Jan 2023
President and CEO
Sold, plan not stated
27,241
$113.81K
0.4%
11 Jun 2021
Director
Sold, plan not stated
40,993
$457.76K
100%
10 Jun 2021
Director
Sold, plan not stated
25,748
$292.43K
98.7%
10 Jun 2021
Director
Sold, plan not stated
25,248
$286.86K
80.0%
10 Jun 2021
Director
Sold, plan not stated
12,874
$147.16K
50.0%
4 Jan 2021
PRESIDENT AND CEO
Sold, plan not stated
18,235
$186.38K
0.4%
11 Jun 2020
Director
Sold, plan not stated
25,245
$251.69K
49.2%
22 Jul 2019
PRESIDENT AND CEO
Sold, plan not stated
12,715
$126.85K
0.3%
22 Jan 2019
PRESIDENT AND CEO
Sold, plan not stated
8,825
$218.33K
0.2%
20 Jul 2018
PRESIDENT AND CEO
Sold, plan not stated
12,520
$651.02K
0.3%
22 Jan 2018
PRESIDENT AND CEO
Sold, plan not stated
10,692
$991.68K
0.3%
22 Jan 2018
Chief Commercial Officer
Sold, plan not stated
1,858
$172.52K
6.8%
22 Jan 2018
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
1,860
$172.52K
6.8%
1 Dec 2017
SEE REMARKS
Sold, plan not stated
1,322
$139.42K
4.4%
29 Sep 2017
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
15,000
$1.80M
35.5%
7 Sep 2017
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
14,000
$1.40M
33.9%
6 Sep 2017
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
1,000
$100.00K
3.5%
20 Jul 2017
PRESIDENT AND CEO
Sold, plan not stated
13,175
$1.25M
0.3%
20 Jul 2017
Chief Commercial Officer
Sold, plan not stated
1,990
$188.85K
6.8%
20 Jul 2017
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
1,998
$188.78K
6.8%
3 Jul 2017
SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
5,000
$435.50K
14.6%
12 Jun 2017
10% owner indirect
Sold, plan not stated
88,944
$7.05M
2.3%
9 Jun 2017
10% owner indirect
Sold, plan not stated
58,316
$4.71M
1.5%
8 Jun 2017
10% owner indirect
Sold, plan not stated
100,000
$8.09M
2.5%
5 Jun 2017
10% owner indirect
Sold, plan not stated
307,128
$28.04M
7.2%
2 Jun 2017
10% owner indirect
Sold, plan not stated
30,475
$2.53M
0.7%
1 Jun 2017
10% owner indirect
Sold, plan not stated
169,525
$13.98M
3.8%
26 May 2017
10% owner indirect
Sold, plan not stated
300,000
$23.12M
6.3%
25 May 2017
10% owner indirect
Sold, plan not stated
400,000
$31.15M
7.8%
24 May 2017
10% owner indirect
Sold, plan not stated
535,700
$38.88M
9.4%
20 Jan 2017
PRESIDENT AND CEO
Sold, plan not stated
10,202
$339.06K
0.2%
Showing 1–39 of 39.